Targeted tumor therapy with the TGF-β2 antisense compound AP 12009

Karl Hermann Schlingensiepen(Vifor Pharma (Germany)), R. Schlingensiepen, Andreas Steinbrecher(University of Regensburg), Peter Hau(University of Regensburg), Ulrich Bogdahn(University of Regensburg), Birgit Fischer-Blass, Piotr Jachimczak
Cytokine & Growth Factor Reviews
December 28, 2005
10.1016/j.cytogfr.2005.09.002
Cited by 194Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis